ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994

BioSeek Awarded NIH SBIR For Compound Validation.

July 4, 2003

In Brief: SBA Writing Guidelines to Implement Act Giving 1.25 Percent Of R&D Budget To Small Business

July 23, 1982

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011

Construction Needs From NCI Said $40 Million Year For Four Years

June 9, 1978

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986